Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olli Kallioniemi

Showing results (121-130 of 185) with videos related to

Pageof 19
Sort By:
International Journal of Cancer|August 21, 2018
Clonal heterogeneity influences drug responsiveness in renal cancer assessed by ex vivo drug testing of multiple patient-derived cancer cellsKhalid Saeed, Poojitha Ojamies, Teijo Pellinen, et al.
NPJ Precision Oncology|May 14, 2026
A multi-center study on the consistency of drug sensitivity testing in patients with acute myeloid leukemiaKatarina Willoch-Allen, Zhi Zhao, Pilar Ayuda-Durán, et al.
Scientific Reports|June 6, 2014
Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapiesBhagwan Yadav, Tea Pemovska, Agnieszka Szwajda, et al.
NPJ Precision Oncology|November 1, 2023
The drug efficacy testing in 3D cultures platform identifies effective drugs for ovarian cancer patientsEmma Åkerlund, Greta Gudoityte, Elisabeth Moussaud-Lamodière, et al.
Cancer Research|January 21, 2006
Profiling genetic variation along the androgen biosynthesis and metabolism pathways implicates several single nucleotide polymorphisms and their combinations as prostate cancer risk factorsNina Mononen, Eija H Seppälä, Priya Duggal, et al.
Molecular Oncology|June 15, 2018
Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancerJarle Bruun, Anita Sveen, Rita Barros, et al.
Molecular Cancer Research : MCR|April 24, 2012
Heparin-like polysaccharides reduce osteolytic bone destruction and tumor growth in a mouse model of breast cancer bone metastasisSirkku Pollari, Rami S Käkönen, Khalid S Mohammad, et al.
Cell Death & Disease|August 17, 2022
Multiomics characterization implicates PTK7 in ovarian cancer EMT and cell plasticity and offers strategies for therapeutic interventionJuuli Raivola, Alice Dini, Hanna Karvonen, et al.
NPJ Precision Oncology|March 5, 2026
Landscape of circular RNAs in acute myeloid leukemia and their clinical significanceThi-Hau Nguyen, Manh-Hung Nguyen, Ha-Nam Nguyen, et al.
Molecular Cancer Therapeutics|July 5, 2018
Drug-Sensitivity Screening and Genomic Characterization of 45 HPV-Negative Head and Neck Carcinoma Cell Lines for Novel Biomarkers of Drug EfficacyTatiana Lepikhova, Piia-Riitta Karhemo, Riku Louhimo, et al.
Pageof 19

Showing results (121-130 of 185) with videos related to

Sort By:
Pageof 19
International Journal of Cancer|August 21, 2018
Clonal heterogeneity influences drug responsiveness in renal cancer assessed by ex vivo drug testing of multiple patient-derived cancer cellsKhalid Saeed, Poojitha Ojamies, Teijo Pellinen, et al.
NPJ Precision Oncology|May 14, 2026
A multi-center study on the consistency of drug sensitivity testing in patients with acute myeloid leukemiaKatarina Willoch-Allen, Zhi Zhao, Pilar Ayuda-Durán, et al.
Scientific Reports|June 6, 2014
Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapiesBhagwan Yadav, Tea Pemovska, Agnieszka Szwajda, et al.
NPJ Precision Oncology|November 1, 2023
The drug efficacy testing in 3D cultures platform identifies effective drugs for ovarian cancer patientsEmma Åkerlund, Greta Gudoityte, Elisabeth Moussaud-Lamodière, et al.
Cancer Research|January 21, 2006
Profiling genetic variation along the androgen biosynthesis and metabolism pathways implicates several single nucleotide polymorphisms and their combinations as prostate cancer risk factorsNina Mononen, Eija H Seppälä, Priya Duggal, et al.
Molecular Oncology|June 15, 2018
Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancerJarle Bruun, Anita Sveen, Rita Barros, et al.
Molecular Cancer Research : MCR|April 24, 2012
Heparin-like polysaccharides reduce osteolytic bone destruction and tumor growth in a mouse model of breast cancer bone metastasisSirkku Pollari, Rami S Käkönen, Khalid S Mohammad, et al.
Cell Death & Disease|August 17, 2022
Multiomics characterization implicates PTK7 in ovarian cancer EMT and cell plasticity and offers strategies for therapeutic interventionJuuli Raivola, Alice Dini, Hanna Karvonen, et al.
NPJ Precision Oncology|March 5, 2026
Landscape of circular RNAs in acute myeloid leukemia and their clinical significanceThi-Hau Nguyen, Manh-Hung Nguyen, Ha-Nam Nguyen, et al.
Molecular Cancer Therapeutics|July 5, 2018
Drug-Sensitivity Screening and Genomic Characterization of 45 HPV-Negative Head and Neck Carcinoma Cell Lines for Novel Biomarkers of Drug EfficacyTatiana Lepikhova, Piia-Riitta Karhemo, Riku Louhimo, et al.
Pageof 19